Duchenne muscular dystrophy complications. 

Duchenne Muscular Dystrophy

The symptoms of Duchenne Muscular Dystrophy (DMD), a severe, genetic muscle-wasting illness that mainly affects boys, often manifest between the ages of two and four. Mutations in the DMD gene cause dystrophin deficiency, which is required for strong muscles. Treatments include gene therapy, steroids, and supportive care, which can delay the disease's course and enhance quality of life, but there is no cure.

Duchenne Muscular Dystrophy

Duchenne muscular dystrophy: what is it?

• An X-linked recessive mutation in the DMD gene causes this genetic disease.
• Protein deficiency: When dystrophin levels are low, muscle fibres degrade and are replaced by scar tissue or fat.
• Prevalence: Approximately 1 in 3,500–5,000 male births globally.

Symptoms

• Toe walking, difficulty running and climbing stairs, frequent falls, and swollen calves are among the early symptoms (ages 2-4).
• Weakness progresses from the hips and thighs to the shoulders, arms, and eventually the heart and breathing muscles.
• Learning difficulties: Some children may exhibit behavioural problems or have delayed speech.

Diagnosis

• Elevated amounts of creatine kinase (CK) in the blood.
• Genetic testing: Verifies DMD gene mutations.
• A muscle biopsy reveals that dystrophin is absent.
• ECG and echocardiography are used in cardiac monitoring to identify heart involvement.

Possible Duchenne Muscular Dystrophy Complications

Complications from Duchenne Muscular Dystrophy (DMD) are progressive and multisystemic, including the heart, lungs, muscles, bones, and even endocrine and neurological systems. The most dangerous consequences of long-term steroid use are osteoporosis, respiratory failure, and cardiomyopathy.

Significant DMD Complications

• Heart-related Issues
• Weak heart muscle, or dilated cardiomyopathy.
• Conduction flaws and arrhythmias.
• One of the main causes of death is progressive heart failure.

Respiratory Issues

• Hypoventilation is caused by weak diaphragm and intercostal muscles.
• Nocturnal hypoxia and sleep apnea.
• This condition increases the risk of respiratory failure and pneumonia.

Orthopaedic and Skeletal

• Muscular imbalance resulting in scoliosis.
• Ankle, knee, and hip contractures.
• Loss of mobility may occur in the early teens.

Metabolic and Endocrine

• Osteoporosis, fractures, delayed puberty, and low stature are all consequences of steroid medication.
• Weight gain or obesity brought on by steroids and decreased mobility.

Cognitive and Neurological

• Cognitive impairment, including concentration problems and learning challenges.
• Neuropsychiatric conditions (autism spectrum characteristics, ADHD).
• epilepsy in certain situations.

Additional Systemic Problems

• Constipation and delayed stomach emptying are examples of digestive issues.
• Urinary: advanced bladder dysfunction.
• Skin: immobility-related pressure sores.

Warning Signs Needing Immediate Medical Attention

• Palpitations or sudden chest discomfort.
• Severe dyspnea or recurrent infections.
• Quick development of fractures or scoliosis.
• Unexplained convulsions or cognitive deterioration.

Tests for DMD problem screening

Heart Examination

• ECG and echocardiogram: baseline by age 6–10, then yearly to assess for arrhythmias or cardiomyopathy.
• More sensitive for fibrosis, cardiac MRI is typically advised every two to three years.
• Silent rhythm abnormalities are detected with Holter monitoring.

Screening of the Respiratory System

• Lung strength and capability are measured by pulmonary function tests (PFTs).
• Sleep studies (polysomnography): look for sleep apnea or nocturnal hypoventilation.
• Blood gas analysis keeps track of carbon dioxide and oxygen levels in patients with advanced illness.

Bone and Orthopedic Screening

• Spinal X-rays monitor the development of scoliosis.
• DEXA scan: evaluates bone density, particularly when using steroids for an extended period of time.
• Physical examination: evaluation of hip, knee, and ankle contractures.

Growth and Endocrine Screening

• Growth charts and puberty evaluation: monitor for short stature or delayed puberty.
• Calcium and vitamin D levels—avoid osteoporosis.
• Weight monitoring: steroids and decreased mobility increase the risk of obesity.

Cognitive and Neurological Screening

• Neuropsychological testing can identify characteristics of autism, ADHD, or learning challenges. Early assistance for communication delays is provided through speech and language examination.
• EEG—if there is a suspicion of seizures.

When Should I Consult a Physician?

Regular medical follow-up is crucial for Duchenne muscular dystrophy (DMD); however, there are several circumstances where consulting a doctor right away becomes essential.

When to Get Medical Help?

Symptoms associated with the heart: 

• Palpitations, irregular heartbeat, or chest discomfort.
• Abdominal or leg swelling that occurs suddenly may indicate cardiac failure.

Breathing problems

• Breathing difficulties while you're sleeping or at rest.
• Headaches in the morning and drowsiness during the day are indicators of hypoventilation at night.
• Pneumonia or recurrent chest infections.

Mobility and bone problems

• Fractures that happen suddenly or scoliosis that worsens.
• Quick loss of the capacity to sit or walk upright.

Complications associated with steroids

• Severe mood swings, developmental delays, or weight gain.
• Recurrent fractures or bone pain.

Neurological issues

• Abrupt behavioural changes, inexplicable fainting, or seizures.
• Substantial learning challenges or skill decline.

Overall warning signs

• Persistent infections or fever.
• Immobility-related skin deterioration or pressure sores.
• Abrupt loss of stamina or strength.

Regular vs. Emergency Visits

• Visit Type Goal Frequency
• Regular examinations include evaluations of the heart, lungs, bones, endocrine system, and nervous system. Every six to twelve months
• For new or worsening symptoms (heart, breathing, fractures, seizures), an urgent visit is necessary. Right away

Drugs used to treat DMD

• Corticosteroids: Vamorolone, deflazacort, and prednisone reduce muscle weakening and postpone loss of gait.
• Eteplirsen (Exondys 51), golodirsen (Vyondys 53), viltolarsen (Viltepso), and casimersen (Amondys 45) are examples of exon-skipping treatments that only address particular mutations.
• Gene therapy: Elevidys (delandistrogene moxeparvovec) provides micro-dystrophin; it was approved in 2023 for children who are ambulatory and older than four years.
• HDAC inhibitor: Givinostat (Duvyzant), authorised for children aged ≥6, decreases muscular fibrosis and inflammation.
• Heart drugs: beta-blockers and ACE inhibitors prevent cardiomyopathy.

The video is about Duchenne muscular dystrophy. 

Supportive Care & Therapy

• Physical treatment: Aquatic therapy, range-of-motion exercises, and stretching to prevent scoliosis and contractures.
• Occupational therapy: Assists with everyday tasks like eating, dressing, and grooming
• Wheelchairs, scooters, standing frames, and braces are examples of assistive aids for safe mobility.
• Respiratory support: ventilators or BiPAP for breathing problems, particularly at night.
• Nutrition: Supplementing with calcium and vitamin D can help prevent osteoporosis.

Orthopaedic and Surgical Interventions

• Contracture release surgery may be required if the joints are extremely stiff.
• Rod insertion for scoliosis during spinal surgery to enhance breathing and sitting

Hazards and Things to Think About

• Steroids: Growth suppression, weight gain, and bone loss.
• Gene therapy: Restricted eligibility (viral antibodies, mutation type).
• Only certain mutations can benefit from exon skipping.
• Cost and accessibility: In India, advanced therapies are costly and scarce.

Prognosis/Mobility: 

• By the time they are 11 or 12 years old, most boys need a wheelchair.
• Life expectancy used to be in the late teens, but with better care, many people now live into their 30s or 40s.
• Complications: Scoliosis, respiratory infections, and heart failure are frequent.

Conclusion

It mainly affects boys, and symptoms start to show up in early childhood. It is a life-limiting condition that eventually results in respiratory failure, cardiomyopathy, and loss of movement. Treatment methods, such as corticosteroids, gene therapy, exon-skipping medications, and supportive care, have greatly increased lifespan and quality of life even though there is no cure. DMD necessitates proactive, lifelong care for the neurological, cardiac, respiratory, and orthopaedic systems. Although access and mutation-specific eligibility continue to be obstacles, new therapeutic developments are providing hope.